Agan, Divine Grace .

HRN: 27-67-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2025
CEFTRIAXONE 1G (VIAL)
08/21/2025
08/27/2025
IV
2g
Od
Uti
Remove - Pending Acceptance
09/02/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/02/2025
09/02/2025
IV
LD
Now
Uremic Encephalopathy
Remove - Pending Acceptance
09/02/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/02/2025
09/09/2025
IV
2.25g
Q6H
Uremic Encephalopathy
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: